ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Vanda Pharmaceuticals, Inc. 

9620 Medical Center Drive
Suite 201
Rockville  Maryland  20850  U.S.A.
Phone: 301-294-9300 Fax: 301-294-1900


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Vanda Pharmaceuticals, Inc. (VNDA) Receives Positive CHMP Opinion For HETLIOZ (Tasimelteon) For The Treatment Of Non-24-Hour Sleep-Wake Disorder In The European Union 4/24/2015 11:20:10 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces The Appointment Of Chief Commercial Officer 4/20/2015 10:50:24 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Announce First Quarter 2015 Financial Results On May 6, 2015 4/16/2015 4:09:58 PM
Vanda Pharmaceuticals, Inc. (VNDA) Announces Trial Date For Fanapt Patent Cases 4/14/2015 6:51:48 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing Of A New Fanapt Patent In The FDA Orange Book 4/9/2015 7:42:49 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces Tradipitant Phase II Proof Of Concept Study Results For Chronic Pruritus In Atopic Dermatitis 3/5/2015 6:58:33 AM
Vanda Pharmaceuticals, Inc. (VNDA) Reports Fourth Quarter 2014 And Full Year 2014 Financial Results 2/19/2015 9:08:02 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Announce Fourth Quarter 2014 Financial Results On February 19, 2015 2/3/2015 10:43:42 AM
Vanda Pharmaceuticals, Inc. (VNDA) To Participate In The Canaccord Genuity Rare Disease, Biopharma One-On-One Day 1/30/2015 10:28:38 AM
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing of a New FanaptĀ® Patent In The FDA Orange Book 1/16/2015 9:19:23 AM
12345678910...